AKT1 and breast cancer: Lastly, combinations of curcumin and lapatinib were also found to increase lapatinib-induced inhibition of the Her2-Akt pathway, reverse lapatinib resistance and decrease metastatic potential in breast cancer cells (Liu et al., 2015; Saxena et al., 2020).